PSUSA/00010915/202501

PSUSA/00000259/202502

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 28, Status: Authorised

PSUSA/00003168/202502

Agenda - HMA/EMA Annual Data Forum 2025

Human medicines European public assessment report (EPAR): Zilbrysq, zilucoplan, Date of authorisation: 01/12/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): mResvia, Respiratory syncytial virus mRNA vaccine (nucleoside modified), Date of authorisation: 22/08/2024, Revision: 8, Status: Authorised

Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes

Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)

Transfer of marketing authorisation: questions and answers